Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
05/2009
05/21/2009US20090133134 Method and composition for genetically modifying non-human cells and animals
05/21/2009US20090131669 to replace the fragile proteinaceous ion pores currently used for studying DNA translocation; 1,4-bis(4-ethynylpyridine)benzene complexed with bis(trioctylphosphino)-platinum(II)bis(trifluoromethanesulphonate)
05/21/2009US20090131647 Methods for detecting nucleic acid sequence variations
05/21/2009US20090131642 Synthetic Nanopores for DNA Sequencing
05/21/2009US20090131529 Treatment of breast cancer with a parp inhibitor alone or in combination with anti-tumor agents
05/21/2009US20090131527 Novel anthranilic acid derivatives and chloride channel blocking agent containing the same
05/21/2009US20090131524 Sialic acid abc transporters in prokaryotes therapeutic targets
05/21/2009US20090131495 Method for the prevention and treatment of essential tremor by regulating alpha1g t-type calcium channel or by t-type calcium channel blockers
05/21/2009US20090131474 Screening methods for protein kinase b inhibitors employing virtual docking approaches and compounds and compositions discovered thereby
05/21/2009US20090131451 Diagnosis and treatment of type 2 diabetes and other disorders
05/21/2009US20090131361 Novel Use of MLN51 Gene and Protein
05/21/2009US20090131359 Antifibrotic therapy
05/21/2009US20090131356 miR-15, miR-26, miR-31, miR-145, miR-147, miR-188, miR-215, miR-216, miR-331, mmu-miR-292-3P REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
05/21/2009US20090131354 miR-126 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
05/21/2009US20090131353 Using cyclic nucleotide phosphodiesterase profiles as tool in detection of cell proliferative disorders
05/21/2009US20090131348 Micrornas differentially expressed in pancreatic diseases and uses thereof
05/21/2009US20090131346 Antibody and method for identification of dendritic cells
05/21/2009US20090131344 Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives
05/21/2009US20090131309 Ica512 couples insulin secretion and gene expression in beta-cells
05/21/2009US20090131277 Prostate cancer diagnosis and treatment
05/21/2009US20090131276 Diagnostic kits and methods for scd or sca therapy selection
05/21/2009US20090131275 Method For Preparing Genome Library, And Genome Library Prepared By The Method
05/21/2009US20090131272 Transposition of maize ac/ds elements in vertebrates
05/21/2009US20090131270 Methods for the detection of molecular interactions within cells
05/21/2009US20090131266 Nucleic Acid-Like Proteins
05/21/2009US20090130749 Temperature-Controlled Incubator Having Rotatable Door
05/21/2009US20090130744 Apparatus and method to measure platelet contractility
05/21/2009US20090130737 Novel fungal proteins and nucleic acids encoding same
05/21/2009US20090130736 Using protein denaturant and aprotic solvent to recover RNA for use in genetic analysis
05/21/2009US20090130718 Gene site saturation mutagenesis
05/21/2009US20090130703 Methods of Detection of Changes in Cells
05/21/2009US20090130702 LSD uses quantitative allele peak data derived obtained from a sample containing the DNA of more than one contributor to resolve the best-fit genotype profile of each contributor; computer software
05/21/2009US20090130701 Novel sequence variants of multi-drug resistance genes, mdr1 and mrp1, and recombinant cells expressing mrp1 and mdr1 for assessment of drug penetration and disposition
05/21/2009US20090130700 Device and Method for Determining the Concentration of a Substance
05/21/2009US20090130699 Method for testing substances on biomatrices
05/21/2009US20090130698 Customizable and renewable nanostructured interface for bioelectronic applications
05/21/2009US20090130697 Biological systems input-output response system and plant sentinels
05/21/2009US20090130696 HDL Cholesterol Sensor Using Selective Surfactant
05/21/2009US20090130695 Isolated nucleic acid encoding GEF-H1b polypeptide (Guanine nucleotide exchange factors); diagnosing abnormal cell proliferation and drug screening; measuring phosphorylation by p-21 activated kinase; antitumor agents, anticancer agents
05/21/2009US20090130693 Novel biomarkers for diagnosis and/or prognosis of neoplasias in animals
05/21/2009US20090130692 Use of microproteins as tryptase
05/21/2009US20090130691 Screening proteinase modulators using a chimeric protein and ski-i proprotein convertase substrates and inhibitors
05/21/2009US20090130688 Method for Accessing Microbial Diversity
05/21/2009US20090130687 Formulations and method isolating nucleic acids from arbitrary complex starting materials and subsequent complex genetic materials
05/21/2009US20090130686 Method for the Microscopic Localization of a Selected, Intracellular DNA Segment with a Known Nucleotide Sequence
05/21/2009US20090130685 Plants With Altered Root Architecture, Related Constructs and Methods Involving Genes Encoding Leucine Rich Repeat Kinase (LLRK) Polypeptides and Homologs Thereof
05/21/2009US20090130684 Methods of detecting and treatment of cancers using scutellaria barbata extract
05/21/2009US20090130683 Predicting and diagnosing patients with autoimmune disease
05/21/2009US20090130682 Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
05/21/2009US20090130681 21132, a Human G-protein coupled receptor family member and uses therefor
05/21/2009US20090130680 Solid support
05/21/2009US20090130679 Automated system and method for processing genetic material
05/21/2009US20090130678 Methods and Kits for Breast Cancer Prognosis
05/21/2009US20090130677 Method for isothermal amplification of nucleic acids and method for detecting nucleic acids using simultaneous isothermal amplification of nucleic acids and signal probe
05/21/2009US20090130676 Interaction trap systems for detecting protein interactions
05/21/2009US20090130675 Genes Involved in the Biosynthesis of Thiocoraline and Heterologous Production of Same
05/21/2009US20090130674 Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy
05/21/2009US20090130673 Methods for detecting and differentiating mycobacterium genus and mycobacterium avium complex in a sample or culture
05/21/2009US20090130672 Methods for identifying novel pesticidal gene homologues
05/21/2009US20090130671 Probe, probe set, probe-immobilized carrier, and genetic testing method
05/21/2009US20090130670 Probe, probe set, probe-immobilized carrier, and genetic testing method
05/21/2009US20090130669 Probe, probe set, probe-immobilized carrier, and genetic testing method
05/21/2009US20090130668 Probe, probe set, probe-immobilized carrier, and genetic testing method
05/21/2009US20090130667 Probe, probe set, probe-immobilized carrier, and genetic testing method
05/21/2009US20090130666 Cytometric system including nucleic acid sequence amplification, and method
05/21/2009US20090130665 Polymer compositions and uses thereof
05/21/2009US20090130664 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance in pseudomonas aeruginosa
05/21/2009US20090130663 Hybridization Detection Method Using an Intercalator
05/21/2009US20090130662 Method for Diagnosis of Prostate Cancer
05/21/2009US20090130661 Method for Detecting IL-16 Activity and Modulation of IL-16 Activity Based on Phosphorylated Stat-6 Proxy Levels
05/21/2009US20090130660 Single Nucelotide Polymorphism (SNP)
05/21/2009US20090130659 Kits and methods for detecting methylated dna
05/21/2009US20090130658 implementation of an inexpensive, simply manageable, complete DNA or protein analysis process in a miniaturized cartridge; has microchannels or microcavities that include geometrical structures for receiving dry reagents
05/21/2009US20090130657 Detecting the methylation status of a target region of a nucleic acid molecule using an intercalating nucleic acid containing two or more internal intercalating pseudonucleotides, preferably a phosphoramidite of 1-(4,4'-dimethoxytriphenylmethyloxy)-3-pyrenemethyloxy-2-propanol
05/21/2009US20090130656 Neisseria gonorrhoeae detection
05/21/2009US20090130655 Detection method using nanoaggregate-embedded beads and system thereof
05/21/2009US20090130654 Method for screening hiv drug sensitivity
05/21/2009US20090130653 Interference Control Panel for Evaluation of Analytical Assays for Samples Derived from Blood
05/21/2009US20090130652 Optimization of West Nile Virus Antibodies
05/21/2009US20090130651 Variants of hepatitis b virus with resistance to anti-viral nucleoside agents and applications thereof
05/21/2009US20090130650 Methods for the production of highly sensitive and specific cell surface probes
05/21/2009US20090130649 Methods for Genotyping HVC
05/21/2009US20090130648 Oxidized Phospholipids
05/21/2009US20090130195 Prostate carcinogenesis predictor
05/21/2009US20090130134 T CD4+ Epitopes of Type I and II Latency Antigens of the Epstein-Barr Virus, Which Can Be Recognized by the majority of individuals in the caucasian populations and applications thereof
05/21/2009US20090130132 Anti-caveolin-1 polyclonal antibody, and antigen peptide sequence and method for preparing the same
05/21/2009US20090130123 Antibodies to west nile virus polypeptides
05/21/2009US20090130116 Use of CEACAM8-Specific Substances for Treating Autoimmune Diseases and a Method for Screening Substances Which Induce Apoptosis
05/21/2009US20090130109 DCL-1 and uses thereof
05/21/2009US20090130108 N-Cadherin and Ly6 E: Targets for Cancer Diagnosis and Therapy
05/21/2009US20090130096 Gene Signature of Early Hypoxia to Predict Patient Survival
05/21/2009US20090130091 Compounds for hedgehog pathway blockade in proliferative disorders, including hematopoietic malignancies
05/21/2009US20090130088 Compositions and methods for regulating RNA translation via CD154 CA-dinucleotide repeat
05/21/2009US20090130087 Method for measuring the content of a botulinum toxin in a formulation
05/21/2009US20090130081 Method for treating pervasive development disorders
05/21/2009US20090130071 Soybean Plant And Seed Corresponding To Transgenic Event MON87701 And Methods For Detection Thereof
05/21/2009US20090130067 Cell Population Having Immunoregulatory Activity, Method for Isolation and Uses
05/21/2009US20090130064 Differentiation of stem cells and stabilization of phenotypical properties of primary cells
05/21/2009US20090130063 Process for separating and determining the viral load in a pancreatin sample
05/21/2009US20090127136 Electrode